Rep. April McClain Delaney Sells Off Shares of Labcorp Holdings Inc. (NYSE:LH)

Key Points

• Rep. April McClain Delaney sold $100,001–$250,000 of Labcorp shares on August 25, along with similarly sized stakes in several other companies, including Wabtec, Viking, Trimble and TransDigm.
• Labcorp reported quarterly EPS of $4.99, above the $4.78 consensus estimate, while revenue rose 5.8% year over year to $3.73 billion. The company reaffirmed fiscal 2026 EPS guidance of $18.10–$18.55 and announced a $0.72 quarterly dividend.
• Analysts remain broadly positive, with nine Buy ratings and three Holds and an average price target of $330; however, Labcorp shares were reported down 4.2% and several company insiders have recently sold stock under pre-arranged trading plans.

Representative April McClain Delaney (Democratic-Maryland) recently sold shares of Labcorp Holdings Inc. NYSE: LH. In a filing disclosed on September 09th, the Representative disclosed that they had sold between $100,001 and $250,000 in Labcorp stock on August 25th.

Representative April McClain Delaney also recently made the following trade(s):

• Sold $100,001 - $250,000 in shares of Wabtec NYSE: WAB on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Viking NYSE: VIK on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Trimble NASDAQ: TRMB on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Transdigm Group NYSE: TDG on 8/25/2026.
• Sold $15,001 - $50,000 in shares of Tractor Supply NASDAQ: TSCO on 8/25/2026.
• Sold $15,001 - $50,000 in shares of Middleby NASDAQ: MIDD on 8/25/2026.
• Sold $15,001 - $50,000 in shares of Teledyne Technologies NYSE: TDY on 8/25/2026.
• Sold $100,001 - $250,000 in shares of STERIS NYSE: STE on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Somnigroup International NYSE: SGI on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Signet Jewelers NYSE: SIG on 8/25/2026.

Labcorp Stock Down 4.2%

Shares of NYSE LH opened at $307.77 on Friday. Labcorp Holdings Inc. has a 52 week low of $244.52 and a 52 week high of $341.80. The company has a quick ratio of 1.53, a current ratio of 1.80 and a debt-to-equity ratio of 0.69. The firm's fifty day moving average is $309.90 and its 200 day moving average is $281.74. The company has a market cap of $24.96 billion, a price-to-earnings ratio of 25.46, a PEG ratio of 1.82 and a beta of 0.88.

Labcorp (NYSE:LH - Get Free Report) last posted its earnings results on Thursday, July 30th. The medical research company reported $4.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.78 by $0.21. The firm had revenue of $3.73 billion for the quarter, compared to analysts' expectations of $3.71 billion. Labcorp had a return on equity of 16.74% and a net margin of 6.99%.The business's revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.35 earnings per share. Labcorp has set its FY 2026 guidance at 18.100-18.550 EPS. On average, equities research analysts expect that Labcorp Holdings Inc. will post 18.32 earnings per share for the current year.

Labcorp Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, August 28th. Labcorp's payout ratio is presently 23.82%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. JPMorgan Chase & Co. upped their target price on Labcorp from $330.00 to $360.00 and gave the stock an "overweight" rating in a report on Monday, August 3rd. Truist Financial increased their price objective on Labcorp from $320.00 to $350.00 and gave the stock a "buy" rating in a report on Friday, July 31st. Robert W. Baird set a $352.00 target price on shares of Labcorp in a report on Friday, July 31st. Morgan Stanley increased their price target on shares of Labcorp from $308.00 to $338.00 and gave the stock an "overweight" rating in a research note on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft reissued a "hold" rating and set a $306.00 price target on shares of Labcorp in a research report on Friday, July 31st. Nine investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Labcorp has an average rating of "Moderate Buy" and an average target price of $330.00.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. California State Teachers Retirement System grew its holdings in Labcorp by 28,952.8% during the 2nd quarter. California State Teachers Retirement System now owns 35,002,800 shares of the medical research company's stock valued at $9,800,784,000 after buying an additional 34,882,320 shares in the last quarter. Victory Capital Management Inc. grew its holdings in shares of Labcorp by 103.1% in the fourth quarter. Victory Capital Management Inc. now owns 5,356,825 shares of the medical research company's stock valued at $1,343,922,000 after purchasing an additional 2,719,475 shares in the last quarter. Boston Partners purchased a new position in shares of Labcorp in the fourth quarter valued at $480,271,000. Norges Bank bought a new stake in Labcorp in the fourth quarter worth $248,006,000. Finally, Diamond Hill Capital Management LLC Investment Advisor bought a new stake in Labcorp in the second quarter worth $168,222,000. 95.94% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Labcorp

In related news, Director Kerrii B. Anderson sold 3,000 shares of Labcorp stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $318.02, for a total value of $954,060.00. Following the completion of the transaction, the director owned 6,563 shares in the company, valued at approximately $2,087,165.26. This trade represents a 31.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Adam H. Schechter sold 4,669 shares of the company's stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $320.37, for a total value of $1,495,807.53. Following the sale, the chief executive officer owned 102,565 shares in the company, valued at approximately $32,858,749.05. This trade represents a 4.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 8,919 shares of company stock valued at $2,826,593 over the last ninety days. Corporate insiders own 0.84% of the company's stock.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland's 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland's 6th Congressional District. She declared candidacy for the 2026 election. April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor's degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

Labcorp Company Profile

Labcorp NYSE: LH, formerly Laboratory Corporation of America Holdings, is a global life sciences and laboratory services company headquartered in Burlington, North Carolina. The company provides diagnostic testing and related services to physicians, hospitals, health systems, employers, government agencies and consumers.

Its diagnostics business offers routine and specialty laboratory testing, including molecular, genetic, oncology, women's health, infectious disease and pathology services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.